Delivery Order SPE2DB20D3505-SPE2DB25FYBSP
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,845.42 on August 5, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 6, 2025, and performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order was issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units. This contract is valued at $2,284.62 under a firm fixed-price delivery order arrangement with no set-aside designation, indicating the award was made through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units. This firm fixed-price delivery order, valued at $3,215.82, represents a non-competitive set-aside contract with an ultimate completion date of July 28, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for OxyContin ER 10 mg tablets (100-count units) valued at $1,494.12. This is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, to be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating it was competitively awarded. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) valued at $2,707.18, with a firm fixed price structure and completion deadline of August 4, 2025. This non-set-aside award, issued on August 1, 2025, represents a single delivery order under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units. The contract is valued at $3,667.68 with a firm fixed-price structure and is scheduled for completion by August 6, 2025. This competitively awarded delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency (DLA) awarded a $2,142.97 delivery order to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count packages) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract, which received no set-aside designation, was competitively awarded and represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical will be supplied from the vendor's corporate office...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,924.20 for OxyContin ER 10 mg tablets (100-count) with an ultimate completion date of July 30, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 3, 2025, for the supply of OxyContin tablets 20mg, with a ceiling value of $3,304.45. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) valued at $1,458.52, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single transaction under the contractor's larger pharmaceutical supply relationship with the federal government. The place of performance is AmerisourceBergen's corporate office...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FYBSPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for OxyContin ER 20 mg tablets (100-count) with a ceiling value of $2,070.62. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to supply a broad range of pharmaceutical products including brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The DLA Medical Supply Chain relies on AmerisourceBergen as a prime vendor through competitive delivery orders with consistent firm fixed-price arrangements, enabling efficient fulfillment of pharmaceutical requirements across the Department of Defense healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/18/25 |